Establishes a program to maintain reserves of critical drugs and active pharmaceutical ingredients to prevent supply disruptions during shortages or.
The RAPID Reserve Act aims to improve supply chain resiliency for critical drugs with vulnerable supply chains. The Secretary of Health and Human Services will award contracts or cooperative agreements to eligible entities for drugs and active pharmaceutical ingredients deemed critical and vulnerable. Eligible entities must maintain a reserve of these ingredients and finished drug products, regularly replenished. The Secretary will prioritize entities that strengthen domestic manufacturing and capacity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.